PHYCUT: Scalable Multiplex CRISPR/Cas9 Editing for Genome Engineering in the Diatom Phaeodactylum tricornutum
ACS Synthetic Biology · 2026
DOI: 10.1021/acssynbio.5c00843 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Emily E Stuckless und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University, London ON N6A 5C1, Canada. Hauptthemen laut MEDLINE: Diatoms, CRISPR-Cas Systems, Genetic Engineering. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Government of Ontario.
Abstract (Originalsprache)
Diatoms are globally significant microalgae that contribute ∼20% of oxygen production and exhibit remarkable metabolic diversity. The marine diatom Phaeodactylum tricornutum has emerged as a promising synthetic biology platform for the bioproduction of recombinant proteins, supported by a human-like N-linked glycosylation pathway. However, its α(1,3)-linked core fucose is potentially immunogenic in humans and thus limits its biopharmaceutical applications. One hurdle to efficient genome engineering in P. tricornutum is the lack of a robust system for simultaneous CRISPR/Cas9 editing at multiple sites. To overcome this limitation, we develop PHYCUT (Phaeodactylum tricornutum Csy4-Cas9 multiplex tool), a versatile plasmid-based CRISPR/Cas9 system that uses the Csy4 endoribonuclease to process multiguide RNA arrays. To highlight PHYCUT applications, we demonstrate multiplex editing of all three FucT genes responsible for α(1,3) fucosylation in P. tricornutum, yielding strains with reduced fucosylation of secreted proteins. PHYCUT enables facile, multiplexed genome engineering in diatoms and provides a foundation for humanizing the P. tricornutum glycosylation pathway to support next-generation algal biotechnology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University, London ON N6A 5C1, Canada.
ORCID-Profile: David R Edgell
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Government of Ontario
Zitieren
APA
Stuckless, E. E., Gai, L. S., Slattery, S. S., Dempsey, K. H., Browne, T. S., Gloor, G. B., & Edgell, D. R. (2026). PHYCUT: Scalable Multiplex CRISPR/Cas9 Editing for Genome Engineering in the Diatom Phaeodactylum tricornutum. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.5c00843
Vancouver
Stuckless EE, Gai LS, Slattery SS, Dempsey KH, Browne TS, Gloor GB, et al. PHYCUT: Scalable Multiplex CRISPR/Cas9 Editing for Genome Engineering in the Diatom Phaeodactylum tricornutum. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.5c00843
BibTeX
@article{Stuckless2026,
author = {Stuckless, Emily E and Gai, Lian S and Slattery, Samuel S and Dempsey, Kira H and Browne, Tyler S and Gloor, Gregory B and Edgell, David R},
title = {PHYCUT: Scalable Multiplex CRISPR/Cas9 Editing for Genome Engineering in the Diatom Phaeodactylum tricornutum},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.5c00843}
}
EUVIMED